+794.9%
MRNA vs AMDL
+130.1%
+664.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AMDL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -17.6% | +14.1% | -1.8% |
| 7D | -12.1% | +37.2% | -49.3% | -15.3% |
| 30D | -1.3% | -24.0% | +22.7% | -0.9% |
| 3M | +250.9% | -1.0% | +252.0% | +243.8% |
| 6M | +343.0% | -3.2% | +346.2% | +310.2% |
| YTD | +657.4% | +232.2% | +425.2% | +392.1% |
| 1Y | +794.9% | +137.7% | +657.2% | +521.5% |
| All | +794.9% | +130.1% | +664.8% | +521.5% |
Cumulative growth
Daily Returns
Daily percentage return beside AMDL.
Daily Out/Under-Performance
Portfolio return minus AMDL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMDL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AMDL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling